Align Technology (NASDAQ: ALGN) and Invacare Corporation (NYSE:IVC) are both large-cap medical equipment, supplies & distribution – nec companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends and earnings.

Institutional and Insider Ownership

81.0% of Align Technology shares are owned by institutional investors. Comparatively, 94.7% of Invacare Corporation shares are owned by institutional investors. 1.6% of Align Technology shares are owned by company insiders. Comparatively, 2.6% of Invacare Corporation shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility & Risk

Align Technology has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Comparatively, Invacare Corporation has a beta of 2.4, indicating that its stock price is 140% more volatile than the S&P 500.


Invacare Corporation pays an annual dividend of $0.05 per share and has a dividend yield of 0.3%. Align Technology does not pay a dividend. Invacare Corporation pays out -2.6% of its earnings in the form of a dividend.

Earnings and Valuation

This table compares Align Technology and Invacare Corporation’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Align Technology $1.08 billion 17.92 $189.68 million $3.29 73.36
Invacare Corporation $1.05 billion 0.47 -$42.85 million ($1.93) -7.80

Align Technology has higher revenue and earnings than Invacare Corporation. Invacare Corporation is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.


This table compares Align Technology and Invacare Corporation’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Align Technology 19.98% 25.60% 18.04%
Invacare Corporation -6.42% -12.79% -5.88%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Align Technology and Invacare Corporation, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology 0 0 10 0 3.00
Invacare Corporation 0 1 2 0 2.67

Align Technology presently has a consensus target price of $213.20, indicating a potential downside of 11.66%. Invacare Corporation has a consensus target price of $14.50, indicating a potential downside of 3.65%. Given Invacare Corporation’s higher probable upside, analysts plainly believe Invacare Corporation is more favorable than Align Technology.


Align Technology beats Invacare Corporation on 9 of the 15 factors compared between the two stocks.

About Align Technology

Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.

About Invacare Corporation

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with's FREE daily email newsletter.